Bachem signs follow-on contract
Bachem has signed a further work order with an unnamed customer for large volumes of peptides for a minimum total of CHF 1 billion from 2025 to 2029. This follows two previous large-volume contracts announced in September worth CHF 175 million in 2023-4. No further details will be disclosed.
The peptides will be supplied out of Building K (pictured), the new large-scale production facility that is currently under construction at the main site in Bubendorf, Switzerland. This is due to open in 2024 and will more than double manufacturing capacity at the site. Bachem is also intending to invest some CHF 750 million up to 2030 to build on a newly acquired site at Sisslerfeld.